JPS57197295A - Manufacture of daunorubicin-protein composite body - Google Patents

Manufacture of daunorubicin-protein composite body

Info

Publication number
JPS57197295A
JPS57197295A JP57074640A JP7464082A JPS57197295A JP S57197295 A JPS57197295 A JP S57197295A JP 57074640 A JP57074640 A JP 57074640A JP 7464082 A JP7464082 A JP 7464082A JP S57197295 A JPS57197295 A JP S57197295A
Authority
JP
Japan
Prior art keywords
daunorubicin
manufacture
composite body
protein composite
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57074640A
Other languages
Japanese (ja)
Inventor
Tsumino Furanko
Ganbetsuta Romoro
Penko Serujio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISUTEITSUUTO NATSUIONAARE PERU
ISUTEITSUUTO NATSUIONAARE PERU RO SUTSUDEIO E RA KURA DEI TSUMORI
Pfizer Italia SRL
Original Assignee
ISUTEITSUUTO NATSUIONAARE PERU
ISUTEITSUUTO NATSUIONAARE PERU RO SUTSUDEIO E RA KURA DEI TSUMORI
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISUTEITSUUTO NATSUIONAARE PERU, ISUTEITSUUTO NATSUIONAARE PERU RO SUTSUDEIO E RA KURA DEI TSUMORI, Carlo Erba SpA filed Critical ISUTEITSUUTO NATSUIONAARE PERU
Publication of JPS57197295A publication Critical patent/JPS57197295A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
JP57074640A 1981-05-08 1982-05-06 Manufacture of daunorubicin-protein composite body Pending JPS57197295A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8114167 1981-05-08

Publications (1)

Publication Number Publication Date
JPS57197295A true JPS57197295A (en) 1982-12-03

Family

ID=10521675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57074640A Pending JPS57197295A (en) 1981-05-08 1982-05-06 Manufacture of daunorubicin-protein composite body

Country Status (3)

Country Link
JP (1) JPS57197295A (en)
BE (1) BE893109A (en)
DE (1) DE3205847A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05239963A (en) * 1991-08-09 1993-09-17 Fujitsu Ten Ltd Electronic lock device for car door
JPH05239961A (en) * 1991-08-09 1993-09-17 Fujitsu Ten Ltd Electronic lock device for car door

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51126281A (en) * 1975-02-04 1976-11-04 Searle & Co Cytootoxic substance
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51126281A (en) * 1975-02-04 1976-11-04 Searle & Co Cytootoxic substance
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05239963A (en) * 1991-08-09 1993-09-17 Fujitsu Ten Ltd Electronic lock device for car door
JPH05239961A (en) * 1991-08-09 1993-09-17 Fujitsu Ten Ltd Electronic lock device for car door

Also Published As

Publication number Publication date
DE3205847A1 (en) 1982-12-16
BE893109A (en) 1982-08-30

Similar Documents

Publication Publication Date Title
DE3260285D1 (en) Composite body
JPS57182301A (en) Composite body of sugar-containing compound and cycloamlose and manufacture
JPS5738137A (en) Manufacture of composite member
JPS57150628A (en) Manufacture of alpha-alkylacrolein
JPS57193374A (en) Manufacture of jet-nozzle-duct
JPS57100429A (en) Manufacture of structural body
JPS57149605A (en) Assembled body of brake
JPS57154140A (en) Manufacture of hydroxyarylophenone
JPS57208328A (en) Assembled body of brake
JPS57203037A (en) Manufacture of p-nitrophenetol
JPS57212145A (en) Manufacture of cyclohexyamine
JPS57185286A (en) Manufacture of isosorbit-5-nitrate
GB2112689B (en) Manufacture of composite tube
JPS57140389A (en) Manufacture of composite fertilizer
JPS57149245A (en) Manufacture of polychlorobenzoylchloride
JPS57159759A (en) Manufacture of 4-haloazetidine-2-ones
JPS57138935A (en) Manufacture of composite membrane
JPS5542234A (en) Manufacture of gypsummresin composite body
JPS57182435A (en) Manufacture of laminate
JPS57203075A (en) Manufacture of halogen-2-mercaptobenzoxazole
JPS57135761A (en) Calcium silicate-resin composite body and manufacture
JPS57195656A (en) Manufacture of composite shape
JPS57209294A (en) Manufacture of silylisocyanate
JPS57197295A (en) Manufacture of daunorubicin-protein composite body
JPS57156381A (en) Manufacture of ceramic-metal composite body